Figure 2From: Effect of engineered TiO2and ZnO nanoparticles on erythrocytes, platelet-rich plasma and giant unilamelar phospholipid vesiclesRelative number of agglomerated engineered nanoparticles distributed over size. The height of the column represents the number of agglomerated engineered nanoparticles pertaining to a given size interval, divided by the number of all agglomerated engineered nanoparticles measured. Left: the relative number of glucose-suspended TiO2 agglomerated engineered nanoparticles, right: the relative number of glucose-suspended ZnO agglomerated engineered nanoparticles, as measured by the dynamic light scattering method.Back to article page